Kümmel, S., Holtschmidt, J. C., Gerber, B., Assen, A. v. d., Heil, J., Thill, M., . . . Reinisch, M. (2019). Prospective, multicenter, randomized phase III trial evaluating the impact of lymphoscintigraphy as part of sentinel node biopsy in early breast cancer: SenSzi (GBG80) Trial. Journal of clinical oncology, 37(17), . https://doi.org/10.1200/JCO.18.02092
Chicago Style (17th ed.) CitationKümmel, Sherko, et al. "Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial." Journal of Clinical Oncology 37, no. 17 (2019). https://doi.org/10.1200/JCO.18.02092.
MLA (9th ed.) CitationKümmel, Sherko, et al. "Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial." Journal of Clinical Oncology, vol. 37, no. 17, 2019, https://doi.org/10.1200/JCO.18.02092.